US Pharma MarketingThe MIT spinout will use the financing, from investors and the European Investment Bank, to accelerate the U.S. launch of its Coaptium sutureless nerve repair technology.
Tissium secures up to $68M to back rollout of nerve repair platform
The MIT spinout will use the financing, from investors and the European Investment Bank, to accelerate the U.S. launch of its Coaptium sutureless nerve repair technology.
Source: MedTech Dive